Coca-Cola tops earnings and revenue estimates but says demand for drinks is still soft

Coca-Cola tops earnings and revenue estimates but says demand for drinks is still soft


Sina Schuldt | Picture Alliance | Getty Images

Coca-Cola reported quarterly earnings and revenue that topped expectations, but the beverage giant said that demand for its drinks is still soft.

Here’s what the company reported compared with what Wall Street analysts surveyed by LSEG were expecting:

  • Earnings per share: 82 cents adjusted vs. 78 cents expected
  • Revenue: $12.41 billion adjusted vs. $12.39 billion expected

Coke reported third-quarter net income attributable to shareholders of $3.7 billion, or 86 cents per share, up from $2.85 billion, or 66 cents per share, a year earlier.

Excluding restructuring charges and other items, Coke earned 82 cents per share.

Net sales rose 5% to $12.46 billion. Coke’s organic revenue, which strips out acquisitions, divestitures and foreign currency, increased 6%.

The company’s unit case volume rose 1%, a reversal from last quarter’s decline. The metric excludes the impact of pricing and foreign currency to reflect demand.

But volume in both Latin America and North America, two key markets, was flat for the quarter. Coke executives have previously said that low-income consumers in the U.S. have been buying fewer of its products, although the company is trying to target them with affordable options.

The company reiterated its full-year forecast. Coke is expecting comparable earnings per share to rise 3% and organic revenue to increase 5% to 6%.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More